As of 2026-11-14, the Fair Value of Tarsus Pharmaceuticals, Inc. (TARS) is -71.82 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 80.28 USD, the upside of Tarsus Pharmaceuticals, Inc. is -189.46%.
With the market price of 80.28 USD and our fair value calculation, Tarsus Pharmaceuticals, Inc. (TARS) is not a good investment. Investing in TARS stocks now will result in a potential loss of 189.46%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -13.83 | -62.09 | -135.89 | -115.55 | -66.42 | -78.76 |
| YoY growth | 48.41% | -348.95% | -118.86% | 14.97% | 42.52% | -72.38% |
| Market Cap (mil) | 3,924.89 |
| P/E | |
| Forward P/E |
| EPS | -14.36 |
| Avg earnings growth rate | -72.38% |
| TTM earnings | -702.23 |